Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The complex role of MEG3: An emerging long non-coding RNA in breast cancer
Md Sadique Hussain, Abdullah A. Majami, Ali Haider, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154850-154850
Closed Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Overcoming chemoresistance and radio resistance in prostate cancer: The emergent role of non-coding RNAs
Muhammad Sarfraz, Abida Khan, Lina Eltaib, et al.
Pathology - Research and Practice (2024) Vol. 255, pp. 155179-155179
Closed Access | Times Cited: 3
Identification and Validation of T-Cell Exhaustion Signature for Predicting Prognosis and Immune Response in Pancreatic Cancer by Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data
Yaowu Zhu, Li Kuo Tan, Danju Luo, et al.
Diagnostics (2024) Vol. 14, Iss. 6, pp. 667-667
Open Access | Times Cited: 3
GAS5: A pivotal lncRNA in diabetes mellitus pathogenesis and management
Khalid Saad Alharbi
Pathology - Research and Practice (2023) Vol. 253, pp. 154955-154955
Closed Access | Times Cited: 8
Circular RNAs and the JAK/STAT pathway: New frontiers in cancer therapeutics
Waleed Hassan Almalki, Salem Salman Almujri
Pathology - Research and Practice (2024) Vol. 260, pp. 155408-155408
Closed Access | Times Cited: 2
Long Non-coding RNA HOTAIR: A Biomarker and Therapeutic Target in Urological Tumors
Abida Abida, Lina Eltaib, Bshayer Hmdan Alhazmi, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155549-155549
Closed Access | Times Cited: 2
Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential
Selim Afşar, Rahamat Unissa Syed, Weam M. A. Khojali, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 2
Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential
Md Sadique Hussain, Somya Sharma, Alka Kumari, et al.
Epigenomics (2024) Vol. 16, Iss. 23-24, pp. 1453-1464
Closed Access | Times Cited: 2
Non-coding RNAs: Emerging biomarkers and therapeutic targets in ulcerative colitis
Imran Kazmi, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155037-155037
Closed Access | Times Cited: 4
Apoptosis-driven synergistic anti-cancer efficacy of ethyl acetate extract of Memecylon sisparense Gamble leaves and doxorubicin in in-vitro and in-vivo models of triple-negative breast cancer
Uppu Jaya Lakshmi, Veerabhadra Swamy, Syamprasad NP, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155032-155032
Closed Access | Times Cited: 4
From diagnosis to therapy: The transformative role of lncRNAs in eye cancer management
Ali Hazazi, Abdulmajid A. AlShehah, Farhan R. Khan, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155081-155081
Closed Access | Times Cited: 1
The ncRNA-TGF-β axis: Unveiling new frontiers in colorectal cancer research
Khalid Saad Alharbi
Pathology - Research and Practice (2024) Vol. 254, pp. 155138-155138
Closed Access | Times Cited: 1
Targeting the autophagy-miRNA axis in prostate cancer: toward novel diagnostic and therapeutic strategies
Rahamat Unissa Syed, Maali D. Alshammari, Humera Banu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 10, pp. 7421-7437
Closed Access | Times Cited: 1
Exploring ncRNAs in epilepsy: From oxidative stress regulation to therapy
Kumud Pant, Anchal Sharma, Soumya V. Menon, et al.
Brain Research (2024) Vol. 1841, pp. 149089-149089
Closed Access | Times Cited: 1
Exploring the lncRNA-VEGF axis: Implications for cancer detection and therapy
Nahed S. Alharthi, Maryam H. Al-Zahrani, Ali Hazazi, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154998-154998
Closed Access | Times Cited: 3
The dual role of MiR-210 in the aetiology of cancer: A focus on hypoxia-inducible factor signalling
Selim Afşar, Rahamat Unissa Syed, Mohammed Khaled Bin Break, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155018-155018
Closed Access | Times Cited: 3
Bridging autoimmunity and epigenetics: The influence of lncRNA MALAT1
Syam Mohan, Mohammed Ageeli Hakami, Hamad Ghaleb Dailah, et al.
Pathology - Research and Practice (2023) Vol. 254, pp. 155041-155041
Closed Access | Times Cited: 3
Long Non-Coding RNAs in Kidney Injury: A Comprehensive Review
Ramdas Bhat, Preeti Shanbhag
Journal of Prevention Diagnosis and Management of Human Diseases (2024), Iss. 42, pp. 39-52
Open Access
Immunohistochemical Expression of P63 in Breast Lesions Among Sudanese Women
Nabila Abdelrazig Elobaid Elhag, Alkhair Abd Almahmoud Idris
Indian Journal of Gynecologic Oncology (2024) Vol. 22, Iss. 2
Closed Access
From diagnosis to therapy: The critical role of lncRNAs in hepatoblastoma
A. Khuzaim Alzahrani, Abida Khan, Neelam Singla, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155412-155412
Closed Access
Non-Coding RNAs as Therapeutic Targets in Parkinson’s Disease: A Focus on Dopamine
Khalid Saad Alharbi
Pathology - Research and Practice (2024) Vol. 263, pp. 155641-155641
Closed Access
Long non-coding RNAs: regulators of autophagy and potential biomarkers in therapy resistance and urological cancers
S F Wang, Bai Yang, Jie Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Previous Page - Page 2

Scroll to top